AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Seeking other disorders within antenatal serum screening programmes for Down's syndrome. (Editorial: Trisomy 18).
December 22, 2002... Case example: Trisomy 18
It is acccpted that certain requirements need to be met before a screening test is judged to be ethical and worthwhile. (1) Antenatal screening for Down's syndrome and spina bifida meet these conditions. They are...
Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. (Original Paper).
December 22, 2002... Objectives: To investigate the influence of general practitioner (GP) endorsement on participation in screening for colorectal cancer based on a faecal occult blood test (FOBT).
Setting: South Australian residents (n=2400), in 1999, aged >...
Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. (Original Paper).
December 22, 2002... Objectives: To evaluate the effectiveness of mammography service screening.
Setting: Helsinki (population 0.5 million), the capital of Finland, the breast cancer service screening programme was started gradually in 1986.
Materials and...
All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. (Original Paper).
December 22, 2002... Background: It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that disease specific mortality is biased in favour of screening. This...
Repeated mammographic screening reduces breast cancer mortality along the continuum of age. (Original Paper).
December 22, 2002... Objective: The optimal age boundaries for breast cancer screening are still under debate. A case-referent design was used to describe the effect of mammographic screening an breast cancer mortality along the continuum of age, based on a 20 year...
Monitoring women's experiences during three rounds of breast cancer screening: results from a longitudinal study. (Original Paper).
December 22, 2002... Objectives: (a) To monitor experiences of women during three successive rounds of breast screening; (b) to examine the impact of previous experiences (obtained either immediately after the latest mammogram or shortly before the subsequent one)...
An investigation into the number of appointment changes and queries arising as a result of extending breast screening to older women in the United Kingdom. (Short Report).
December 22, 2002... Objective: To compare the number of telephone queries and appointment changes requested by women aged 65-69 with women aged 50-64.
Setting: Department of Health funded demonstration study of extending breast screening to women of 65-69.
...
Estimate of population coverage with the prostate specific antigen (PSA) test to screen for prostate cancer in a metropolitan area of northern Italy. (Short Report).
December 22, 2002... The use of the prostate specific antigen (PSA) test in the period 1999-2000 in a population of 311 822 men, aged 40 years or more, resident in Milan, Italy, was examined. Data were drawn from the outpatient database of the local health...
Routine urinalysis of patients in hospital in Lebanon: how worthwhile is it? (Original Paper).
December 22, 2002... Objectives: To examine the impact of routine urinalysis at admission on inpatient care at a hospital in Lebanon, where physicians perceive it to be a valuable diagnostic tool, in a country where preventive services are underdeveloped and where...
What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. (Original Paper).
December 22, 2002... Objectives: To assess mortality risk in people classified by the Cambridge risk score (CRS), a previously validated simple screening tool for undiagnosed type 2 diabetes that uses only information routinely available in primary care.
...
Maternal screening to prevent neonatal Group B streptococcal disease. (Screening Brief).
December 22, 2002... THE DISORDER
* Onset is rapid and may present as sepsis, meningitis or pneumonia
* Caused by Group B streptococcus (Streptococcus agalactiae), a normal commensal of the gastrointestinal tract and vagina and can be recovered from...
Potential biases in Down syndrome birth prevalence estimation.(letters)(in response to J.K. Morris and others, Journal of Medical Screening, vol. 9, p. 2, 2002 )(Letter to the Editor)
December 22, 2002... Potential biases in Down syndrome birth prevalence estimation
Morris et al have estimated the maternal age-specific birth prevalence of Down's syndrome using over 11 000 cases from the National Down Syndrome Cytogenetic Register (NDSCR)....